Search Beyond News…

Hims & Hers Health faces a securities fraud class action covering trades from August 4, 2025 to July 29, 2026, with a lead plaintiff deadline of November 2, 2026

Executive summary: A securities fraud class action lawsuit was filed against Hims & Hers Health, Inc. (NYSE: HIMS) covering purchases of its stock between August 4, 2025 and July 29, 2026. The lawsuit could result in financial penalties, increased regulatory scrutiny, and potential shareholder losses, affecting the company's valuation and investor confidence.

Who is involved: Hims & Hers Health, Inc., its executives, plaintiffs representing affected shareholders, and the law firms filing the suit.

Likely next: The lead plaintiff selection process will conclude by November 2, 2026, after which the case may move toward class certification, discovery, and possible settlement or trial.

A class action lawsuit was filed against Hims & Hers Health, Inc. alleging securities fraud during the specified class period. The suit follows an earlier FTC complaint that accused the company of misleading investors. Investors now have until early November to seek appointment as lead plaintiff, after which the case will proceed through standard litigation steps.

What's next — scenarios

Base: lead plaintiff appointed, case proceeds (50%)

Company may face modest legal costs and a potential settlement in the tens of millions of dollars.

Upside: early settlement before deadline (30%)

Settlement amount under $20 million, minimal effect on earnings.

Downside: prolonged litigation beyond 2027 (20%)

Potential damages exceed $100 million, adversely affecting HIMS share price.

What to watch

Timeline

Analysis — what this means

Likely next events

Sectors affected

Regulatory implications

Historical parallels

Key entities

Sources

Related cases

Browse the full archive →